Egis acquires Bayer vitamin portfolio in Poland
Hungarian drugmaker Egis yesterday signed an agreement regarding the takeover of the Biovital portfolio of vitamin products from Bayer in Poland, the company told Hungarian news agency MTI today.
Egis did not reveal the price of the transaction, however, it noted that turnover of Biovital vitamins in Poland reaches HUF 1 bln a year.
Egis is a unit of Franceʼs Servier.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.